Abercrombie & Fitch (ANF) 10-Q 6 Dec 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Nov. 02, 2024	Dec. 04, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Nov. 02, 2024
Document Transition Report	false
Entity File Number	001-12107
Entity Registrant Name	Abercrombie & Fitch Co.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	31-1469076
Entity Address, Address Line One	6301 Fitch Path,
Entity Address, City or Town	New Albany,
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43054
City Area Code	(614)
Local Phone Number	283-6500
Title of 12(b) Security	Class A Common Stock, $0.01 Par Value
Trading Symbol	ANF
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		50,372,689
Entity Central Index Key	0001018840
Current Fiscal Year End Date	--02-01
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Income Statement [Abstract]
Net sales	$ 1,208,966	$ 1,056,431	$ 3,363,670	$ 2,827,770
Cost of sales, exclusive of depreciation and amortization	422,034	370,762	1,163,019	1,047,927
Gross profit	786,932	685,669	2,200,651	1,779,843
Stores and distribution expense	419,235	383,883	1,181,154	1,072,662
Marketing, general and administrative expense	190,001	162,510	538,352	449,643
Other operating (income) loss, net	(1,586)	1,256	(3,611)	(4,332)
Operating income	179,282	138,020	484,756	261,870
Interest Expense, Operating	569	8,568	11,538	23,661
Interest (income) expense, net	(8,733)	671	(18,959)	5,211
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	188,015	137,349	503,715	256,659
Income tax expense	54,151	39,617	119,394	82,349
Net income	133,864	97,732	384,321	174,310
Less: Net income attributable to noncontrolling interests	1,885	1,521	5,324	4,634
Net income attributable to A&F	$ 131,979	$ 96,211	$ 378,997	$ 169,676
Net income per share attributable to A&F
Basic	$ 2.59	$ 1.91	$ 7.43	$ 3.38
Diluted	$ 2.50	$ 1.83	$ 7.13	$ 3.25
Weighted-average shares outstanding
Basic	50,951	50,504	51,030	50,138
Diluted	52,869	52,624	53,141	52,154
Other comprehensive income
Foreign currency translation adjustments, net of tax	$ 84	$ (5,042)	$ 1,688	$ (8,567)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	1,461	7,259	834	9,906
Other comprehensive income	1,545	2,217	2,522	1,339
Comprehensive income	135,409	99,949	386,843	175,649
Less: Comprehensive income attributable to noncontrolling interests	1,885	1,521	5,324	4,634
Comprehensive income attributable to A&F	133,524	98,428	381,519	171,015
Interest and Other Income	$ (9,302)	$ (7,897)	$ (30,497)	$ (18,450)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Nov. 02, 2024	Feb. 03, 2024
Current assets:
Cash and equivalents	$ 683,089	$ 900,884
Receivables	111,583	78,346
Inventories	692,596	469,466
Other current assets	112,709	88,569
Total current assets	1,655,767	1,537,265
Property and equipment, net	570,440	538,033
Operating lease right-of-use assets	798,290	678,256
Other assets	245,375	220,679
Total assets	3,269,872	2,974,233
Current liabilities:
Accounts payable	466,303	296,976
Accrued expenses	469,148	436,655
Short-term portion of operating lease liabilities	210,335	179,625
Income taxes payable	36,303	53,564
Total current liabilities	1,182,089	966,820
Long-term liabilities:
Long-term portion of operating lease liabilities	734,918	646,624
Long-term portion of borrowings, net	0	222,119
Other liabilities	92,405	88,683
Total long-term liabilities	827,323	957,426
Stockholders’ equity
Class A Common Stock: $0.01 par value: 150,000 shares authorized and 103,300 shares issued for all periods presented	1,033	1,033
Paid-in capital	416,640	421,609
Retained earnings	3,009,664	2,643,629
Accumulated other comprehensive loss, net of tax (“AOCL”)	(133,446)	(135,968)
Treasury stock, at average cost: 52,929 and 52,800 shares as of November 2, 2024 and February 3, 2024, respectively	(2,046,758)	(1,895,143)
Total Abercrombie & Fitch Co. stockholders’ equity	1,247,133	1,035,160
Noncontrolling interests	13,327	14,827
Total stockholders’ equity	1,260,460	1,049,987
Total liabilities and stockholders’ equity	$ 3,269,872	$ 2,974,233
Treasury Stock, at Average Cost (in shares)	52,929	52,800
Marketable Securities, Current	$ 55,790	$ 0

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - Class A Common Stock - $ / shares shares in Thousands	Nov. 02, 2024	Feb. 03, 2024
Stockholders’ equity
Class A Common Stock, par value	$ 0.01	$ 0.01
Class A Common Stock, shares authorized	150,000	150,000
Class A Common Stock, shares issued	103,300	103,300

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023
Operating activities
Net income	$ 384,321	$ 174,310
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	116,610	105,547
Asset impairment	7,066	4,436
Loss on disposal	2,585	5,164
Deferred Income Tax Expense (Benefit)	(9,881)	(13,620)
Share-based compensation	30,123	29,331
Loss on extinguishment of debt	1,114	1,276
Changes in assets and liabilities:
Inventories	(222,929)	(91,817)
Accounts payable and accrued expenses	184,604	126,842
Operating lease right-of-use assets and liabilities	(2,194)	(30,956)
Income taxes	(19,429)	37,857
Other assets	(70,423)	8,519
Other liabilities	1,189	(6,747)
Net cash provided by operating activities	402,756	350,142
Payments to Acquire Marketable Securities	(55,000)	0
Investing activities
Purchases of property and equipment	(132,040)	(128,601)
Proceeds from Sale of Property, Plant, and Equipment	0	615
Net cash used for investing activities	(187,040)	(127,986)
Financing activities
Repayments of Secured Debt	223,331	50,933
Payments of Debt Issuance Costs	(3,273)	(180)
Purchase of treasury stock	(129,807)	0
Payment, Tax Withholding, Share-based Payment Arrangement	(69,613)	(29,079)
Other financing activities	(6,546)	(6,914)
Net cash used for financing activities	(432,570)	(87,106)
Effect of foreign currency exchange rates on cash	(1,834)	(4,491)
Net (decrease) increase in cash and equivalents, and restricted cash and equivalents	(218,688)	130,559
Cash and equivalents, and restricted cash, beginning of period	909,685	527,569
Purchases of property and equipment accrued in accounts payable	57,005	38,787
Excise tax on share repurchases not yet paid at end of period	250	0
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	(291,289)	(117,959)
Cash paid for interest	9,527	14,165
Cash paid for income taxes	147,733	60,215
Cash received from income tax refunds	448	916
Cash paid for operating lease liabilities	206,413	210,971
Cash and equivalents, and restricted cash and equivalents, end of period	690,997	658,128
Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]
Purchases of property and equipment accrued in accounts payable	57,005	38,787
Excise tax on share repurchases not yet paid at end of period	250	0
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	(291,289)	(117,959)
Cash paid for interest	9,527	14,165
Cash paid for income taxes	147,733	60,215
Cash received from income tax refunds	448	916
Cash paid for operating lease liabilities	$ 206,413	$ 210,971

Consolidated Statements of Stoc

Consolidated Statements of Stockholders Equity Statement - USD ($) shares in Thousands, $ in Thousands		Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Noncontrolling Interest [Member]	Retained Earnings [Member]	AOCI Including Portion Attributable to Noncontrolling Interest [Member]	Treasury Stock, Common
Shares, Outstanding			49,002					54,298
Total Abercrombie & Fitch Co. stockholders’ equity			$ 1,033	$ 416,255		$ 2,368,815	$ (137,527)	$ (1,953,735)
Noncontrolling interests					$ 11,728
Total stockholders' equity		$ 706,569
Income (Loss) Attributable to Noncontrolling Interest, before Tax					4,634
Net Income (Loss) Attributable to Parent		169,676				169,676
Net income		174,310
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture			1,399					(1,399)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture		(29,079)		(32,071)		(52,270)		$ 55,262
Share-based compensation expense		(29,331)		(29,331)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax		9,906
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax		(8,567)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders		(6,357)			(6,357)
Shares, Outstanding			50,141					53,159
Total Abercrombie & Fitch Co. stockholders’ equity			$ 1,033	410,398		2,400,032	(138,405)	$ (1,904,752)
Noncontrolling interests					10,478
Total stockholders' equity		778,784
Income (Loss) Attributable to Noncontrolling Interest, before Tax					1,521
Net Income (Loss) Attributable to Parent		96,211				96,211
Net income		97,732
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture			260					(260)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture		(10,310)		(6,567)		(10,022)		$ 6,279
Share-based compensation expense		(9,684)		(9,684)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax		7,259
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax		(5,042)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders		(1,994)			(1,994)
Shares, Outstanding			50,401					52,899
Total Abercrombie & Fitch Co. stockholders’ equity			$ 1,033	413,515		2,486,221	(136,188)	$ (1,898,473)
Noncontrolling interests					10,005
Total stockholders' equity		876,113
Shares, Outstanding			50,500
Total Abercrombie & Fitch Co. stockholders’ equity		1,035,160	$ 1,033	421,609		2,643,629	(135,968)	$ (1,895,143)
Noncontrolling interests		14,827			14,827
Total stockholders' equity		1,049,987
Income (Loss) Attributable to Noncontrolling Interest, before Tax					5,324
Net Income (Loss) Attributable to Parent		378,997				378,997
Net income		384,321
Treasury Stock, Shares, Acquired	[1]		923					923
Treasury Stock, Value, Acquired, Cost Method	[1]	(130,056)						$ (130,056)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture			794					(794)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture		(69,613)		(35,092)		(12,962)		$ (21,559)
Share-based compensation expense		(30,123)		(30,123)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax		834
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax		1,688
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders		(6,824)			(6,824)
Shares, Outstanding			51,069					52,231
Total Abercrombie & Fitch Co. stockholders’ equity			$ 1,033	408,293		2,877,969	(134,991)	$ (1,945,778)
Noncontrolling interests					14,624
Total stockholders' equity		1,221,150
Income (Loss) Attributable to Noncontrolling Interest, before Tax					1,885
Net Income (Loss) Attributable to Parent		131,979				131,979
Net income		133,864
Treasury Stock, Shares, Acquired	[2]		720					720
Treasury Stock, Value, Acquired, Cost Method	[2]	(100,056)						$ (100,056)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture			22					(22)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture		(2,388)		(1,180)		(284)		$ (924)
Share-based compensation expense		(9,527)		(9,527)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax		1,461
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax		84
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders		(3,182)			(3,182)
Shares, Outstanding			50,371					52,929
Total Abercrombie & Fitch Co. stockholders’ equity		1,247,133	$ 1,033	$ 416,640		$ 3,009,664	$ (133,446)	$ (2,046,758)
Noncontrolling interests		13,327			$ 13,327
Total stockholders' equity		$ 1,260,460
[1] (1) Includes excise tax on share repurchases (1) Includes excise tax on share repurchases

Nature of Business (Notes)

Nature of Business (Notes)	9 Months Ended
	Nov. 02, 2024
Nature of Business [Abstract]
Nature of Business	NATURE OF BUSINESS Abercrombie & Fitch Co. (“A&F”), a company incorporated in Delaware in 1996, through its subsidiaries (collectively, A&F and its subsidiaries are referred to as the “Company”), is a global, digitally-led omnichannel retailer. The Company offers a broad assortment of apparel, personal care products and accessories for men, women and kids, which are sold primarily through its Company-owned stores and digital channels, as well as through various third-party arrangements. The Company manages its business on a geographic basis, consisting of three reportable segments: Americas; Europe, the Middle East and Africa (“EMEA”); and Asia-Pacific (“APAC”). Corporate functions and other income and expenses are evaluated on a consolidated basis and are not allocated to the Company’s segments, and therefore are included as a reconciling item between segment and total operating income.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Nov. 02, 2024
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its financial position, results of operations and cash flows. The Company has interests in Emirati and Kuwaiti business ventures with Majid al Futtaim Lifestyle L.L.C. (“MAF”) and in a United States of America (the “U.S.”) business venture with Dixar L.L.C. (“Dixar”), each of which meets the definition of a variable interest entity (“VIE”). The purpose of the business ventures with MAF is to operate stores in the United Arab Emirates and Kuwait, and the purpose of the business venture with Dixar is to hold the intellectual property related to the Social Tourist brand. The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the operating results, assets and liabilities of these VIEs, with the noncontrolling interests’ (“NCI”) portions of net income presented as net income attributable to NCI on the Condensed Consolidated Statements of Operations and Comprehensive Income and the NCI portion of stockholders’ equity presented as NCI on the Condensed Consolidated Balance Sheets. Fiscal year The Company’s fiscal year ends on the Saturday closest to January 31. This typically results in a fifty-two week year, but occasionally gives rise to an additional week, resulting in a fifty-three week year. Fiscal years are designated in the Condensed Consolidated Financial Statements and notes, as well as the remainder of this Quarterly Report on Form 10-Q, by the calendar year in which the fiscal year commences. All references herein to the Company’s fiscal years are as follows: Fiscal year Year ended/ending Number of weeks Fiscal 2023 February 3, 2024 53 Fiscal 2024 February 1, 2025 52 Fiscal 2025 January 31, 2026 52 Interim financial statements The Condensed Consolidated Financial Statements as of November 2, 2024, and for the thirteen and thirty-nine week periods ended November 2, 2024 and October 28, 2023, are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim consolidated financial statements. Accordingly, the Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in A&F’s Annual Report on Form 10-K for Fiscal 2023 filed with the SEC on April 1, 2024 (the “Fiscal 2023 Form 10-K”). The February 3, 2024 consolidated balance sheet data, included herein, were derived from audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the U.S. (“GAAP”). In the opinion of management, the accompanying Condensed Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly, in all material respects, the financial position, results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for Fiscal 2024. Use of estimates The preparation of financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. Due to the inherent uncertainty involved with estimates, actual results may differ. Additionally, these estimates and assumptions may change as a result of the impact of global economic conditions such as the uncertainty regarding a slowing economy, rising interest rates, continued inflation, fluctuation in foreign exchange rates, and geopolitical concerns, all of which could result in material impacts to the Company’s consolidated financial statements in future reporting periods. Recent accounting pronouncements The Company reviews recent accounting pronouncements on a quarterly basis and has excluded discussion of those not applicable to the Company and those that did not have, or are not expected to have, a material impact on the Company’s consolidated financial statements. The following table provides a brief description of certain accounting pronouncements the Company has not yet adopted and that could affect the Company’s financial statements. Accounting Standards Update (ASU) Description Effect on the financial statements or other significant matters ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures The update modifies the disclosure/presentation requirements of reportable segments. The amendments in the update require the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”) and included within each reported measure of segment profit and loss. The amendments also require disclosure of all other segment items by reportable segment and a description of its composition. Additionally, the amendments require disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. This update is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company's consolidated financial statements. ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures The update requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The update will be effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company's consolidated financial statements. ASU 2024-03 - Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses The update requires a disaggregated disclosure of income statement expenses. The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The update is effective for fiscal years beginning after December 15, 2026 and interim period periods for fiscal years beginning after December 15, 2027. Early adoption is permitted. Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company’s consolidated financial statements. Condensed Consolidated Statements of Cash Flows reconciliation The following table provides a reconciliation of cash and equivalents and restricted cash and equivalents to the amounts shown on the Condensed Consolidated Statements of Cash Flows: (in thousands) Location November 2, 2024 February 3, 2024 October 28, 2023 January 28, 2023 Cash and equivalents Cash and equivalents $ 683,089 $ 900,884 $ 649,489 $ 517,602 Restricted cash and equivalents Other assets 7,908 8,801 8,639 9,967 Cash and equivalents and restricted cash and equivalents $ 690,997 $ 909,685 $ 658,128 $ 527,569 Supply Chain Finance Program Under the supply chain finance (“SCF”) program, which is administered by a third party, the Company’s vendors, at their sole discretion, are given the opportunity to sell receivables from the Company to a participating financial institution at a discount that leverages the Company’s credit profile. The commercial terms negotiated by the Company with its vendors are consistent, irrespective of whether a vendor participates in the SCF program. A participating vendor has the option to be paid by the financial institution earlier than the original invoice due date. The Company’s responsibility is limited to making payment on the terms originally negotiated by the Company with each vendor, regardless of whether the vendor sells its receivable to a financial institution. If a vendor chooses to participate in the SCF program, the Company pays the financial institution the stated amount of confirmed merchandise invoices on the stated maturity date, which is typically 75 days from the invoice date. The agreement with the financial institution does not require the Company to provide assets pledged as security or other forms of guarantees for the SCF program. As of November 2, 2024 and February 3, 2024, $109.3 million and $72.4 million of SCF program liabilities were recorded in accounts payable The following table provides activity in the SCF program for the thirty-nine weeks ended November 2, 2024: Thirty-Nine Weeks Ended (in thousands) November 2, 2024 Confirmed obligations outstanding at the beginning of the period $ 72,376 Invoices confirmed during the period 326,109 Confirmed invoices paid during the period (289,164) Confirmed obligations outstanding at the end of the period $ 109,321
BASIS OF PRESENTATION	Interim financial statements The Condensed Consolidated Financial Statements as of November 2, 2024, and for the thirteen and thirty-nine week periods ended November 2, 2024 and October 28, 2023, are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim consolidated financial statements. Accordingly, the Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in A&F’s Annual Report on Form 10-K for Fiscal 2023 filed with the SEC on April 1, 2024 (the “Fiscal 2023 Form 10-K”). The February 3, 2024 consolidated balance sheet data, included herein, were derived from audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the U.S. (“GAAP”). In the opinion of management, the accompanying Condensed Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly, in all material respects, the financial position, results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for Fiscal 2024.
Supplier Finance Program	Supply Chain Finance Program Under the supply chain finance (“SCF”) program, which is administered by a third party, the Company’s vendors, at their sole discretion, are given the opportunity to sell receivables from the Company to a participating financial institution at a discount that leverages the Company’s credit profile. The commercial terms negotiated by the Company with its vendors are consistent, irrespective of whether a vendor participates in the SCF program. A participating vendor has the option to be paid by the financial institution earlier than the original invoice due date. The Company’s responsibility is limited to making payment on the terms originally negotiated by the Company with each vendor, regardless of whether the vendor sells its receivable to a financial institution. If a vendor chooses to participate in the SCF program, the Company pays the financial institution the stated amount of confirmed merchandise invoices on the stated maturity date, which is typically 75 days from the invoice date. The agreement with the financial institution does not require the Company to provide assets pledged as security or other forms of guarantees for the SCF program. As of November 2, 2024 and February 3, 2024, $109.3 million and $72.4 million of SCF program liabilities were recorded in accounts payable The following table provides activity in the SCF program for the thirty-nine weeks ended November 2, 2024: Thirty-Nine Weeks Ended (in thousands) November 2, 2024 Confirmed obligations outstanding at the beginning of the period $ 72,376 Invoices confirmed during the period 326,109 Confirmed invoices paid during the period (289,164) Confirmed obligations outstanding at the end of the period $ 109,321

Revenue Recognition (Notes)

Revenue Recognition (Notes)	9 Months Ended
	Nov. 02, 2024
Disaggregation of Revenue [Abstract]
Revenue from Contract with Customer [Text Block]	REVENUE RECOGNITION Disaggregation of revenue All revenues are recognized in net sales in the Condensed Consolidated Statements of Operations and Comprehensive Income. For information regarding the disaggregation of revenue, refer to Note 14, “ SEGMENT REPORTING . ” Contract liabilities The following table details certain contract liabilities representing unearned revenue as of November 2, 2024, February 3, 2024, October 28, 2023 and January 28, 2023: (in thousands) November 2, 2024 February 3, 2024 October 28, 2023 January 28, 2023 Gift card liability (1) $ 39,096 $ 41,144 $ 36,506 $ 39,235 Loyalty programs liability 30,648 27,937 24,521 25,640 (1) Includes $17.7 million and $15.5 million of revenue recognized during the thirty-nine weeks ended November 2, 2024 and October 28, 2023, respectively, that was included in the gift card liability at the beginning of February 3, 2024 and January 28, 2023, respectively. The following table details recognized revenue associated with the Company’s gift card program and loyalty programs for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Revenue associated with gift card redemptions and gift card breakage $ 32,680 $ 24,741 $ 96,172 $ 73,391 Revenue associated with reward redemptions and breakage related to the Company’s loyalty programs 16,697 13,710 45,367 37,628

Net Income (Loss) Per Share

Net Income (Loss) Per Share	9 Months Ended
	Nov. 02, 2024
Earnings Per Share [Abstract]
NET LOSS PER SHARE	NET INCOME PER SHARE Net income per basic and diluted share attributable to A&F is computed based on the weighted-average number of outstanding shares of A&F’s Class A Common Stock, $0.01 par value (“Common Stock”). The following table provides additional information pertaining to net income per share attributable to A&F for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Shares of Common Stock issued 103,300 103,300 103,300 103,300 Weighted-average treasury shares (52,349) (52,796) (52,270) (53,162) Weighted-average — basic shares 50,951 50,504 51,030 50,138 Dilutive effect of share-based compensation awards 1,918 2,120 2,111 2,016 Weighted-average — diluted shares 52,869 52,624 53,141 52,154 Anti-dilutive shares (1) 250 445 329 609 (1) Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieved from zero up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.

Fair Value

Fair Value	9 Months Ended
	Nov. 02, 2024
Fair Value Disclosures [Abstract]
FAIR VALUE	FAIR VALUE Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized based on a three-level hierarchy. The three levels of inputs to measure fair value are as follows: • Level 1—inputs are unadjusted quoted prices for identical assets or liabilities that are available in active markets that the Company can access at the measurement date. • Level 2—inputs are other than quoted market prices included within Level 1 that are observable for assets or liabilities, directly or indirectly. • Level 3—inputs to the valuation methodology are unobservable. The lowest level of significant input determines the placement of the entire fair value measurement in the hierarchy. The following table provides the three levels of the hierarchy and the distribution of the Company’s assets measured at fair value on a recurring basis, as of November 2, 2024 and February 3, 2024: Assets and Liabilities at Fair Value as of November 2, 2024 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 149,605 $ 42,209 $ — $ 191,814 Marketable securities (2) — 55,790 — 55,790 Derivative instruments (3) — 2,143 — 2,143 Rabbi Trust assets (4) 1,164 53,553 — 54,717 Restricted cash equivalents (1) 3,317 1,480 — 4,797 Total assets $ 154,086 $ 155,175 $ — $ 309,261 Liabilities: Derivative instruments (3) $ — $ 419 $ — $ 419 Total liabilities $ — $ 419 $ — $ 419 Assets and Liabilities at Fair Value as of February 3, 2024 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 349,174 $ 26,975 $ — $ 376,149 Derivative instruments (3) — 1,092 — 1,092 Rabbi Trust assets (4) 1,164 52,521 — 53,685 Restricted cash equivalents (1) 4,282 1,420 — 5,702 Total assets $ 354,620 $ 82,008 $ — $ 436,628 Liabilities: Derivative instruments (3) $ — $ 539 $ — $ 539 Total liabilities $ — $ 539 $ — $ 539 (1) Level 1 assets consisted of investments in money market funds and U.S. treasury bills. Level 2 assets consisted of time deposits with original maturities of less than three months. (2) Level 2 assets consisted of time deposits with original maturities greater than three months, but less than one year. (3) Level 2 assets and liabilities consisted primarily of foreign currency exchange forward contracts. (4) Level 1 assets consisted of investments in money market funds. Level 2 assets consisted of trust-owned life insurance policies. The Company’s Level 2 assets and liabilities consisted of: • Trust-owned life insurance policies, which were valued using the cash surrender value of the life insurance policies; • Time deposits with original maturities of three months or less, which were recorded at cost, approximating fair value, due to the short-term nature of these investments; • Time deposits with original maturities greater than three months, which were recorded at fair value, which approximates their carrying value, and are primarily based upon quoted vendor or broker priced securities in active markets; and • Derivative instruments, primarily foreign currency exchange forward contracts, which were valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk. Fair value of long-term borrowings The Company’s borrowings were carried at historical cost in the accompanying Condensed Consolidated Balance Sheet as of February 3, 2024. On July 15, 2024 (the “Redemption Date”), Abercrombie & Fitch Management Co. (“A&F Management”) redeemed all of its outstanding senior secured notes at par value, which had a fixed 8.75% interest rate and were scheduled to mature on July 15, 2025 (the “Senior Secured Notes”). As of the Redemption Date, the Senior Secured Notes were no longer deemed outstanding.

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Nov. 02, 2024
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET	PROPERTY AND EQUIPMENT, NET The following table provides property and equipment, net as of November 2, 2024 and February 3, 2024: (in thousands) November 2, 2024 February 3, 2024 Property and equipment, at cost $ 2,602,101 $ 2,509,184 Less: Accumulated depreciation and amortization (2,031,661) (1,971,151) Property and equipment, net $ 570,440 $ 538,033 R efer to Note 8, “ ASSET IMPAIRMENT ,” for details related to property and equipment impairment charges incurred during the thirteen and thirty-nine ended November 2, 2024 and October 28, 2023.

Leases (Notes)

Leases (Notes)	9 Months Ended
	Nov. 02, 2024
Leases [Abstract]
Lessee, Operating Leases [Text Block]	LEASES The Company is a party to leases related to its Company-operated retail stores as well as for certain of its distribution centers, office space, information technology and equipment. The following table provides a summary of the Company’s operating lease costs for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Single lease cost (1) $ 69,167 $ 63,177 $ 193,310 $ 184,172 Variable lease cost (2) 45,715 32,332 137,081 119,809 Operating lease right-of-use asset impairment (3) 233 — 1,043 1,414 Sublease income (1,003) (979) (2,973) (2,959) Total operating lease cost $ 114,112 $ 94,530 $ 328,461 $ 302,436 (1) Includes amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities. (2) Includes variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs. (3) Refer to Note 8, “ ASSET IMPAIRMENT ,” for details related to operating lease right-of-use asset impairment charges. The Company had minimum commitments related to operating lease contracts that have not yet commenced, primarily for certain Company-operated retail stores, of approximately $66.5 million as of November 2, 2024.

Asset Impairment (Notes)

Asset Impairment (Notes)	9 Months Ended
	Nov. 02, 2024
Asset Impairment [Abstract]
Asset Impairment Charges [Text Block]	ASSET IMPAIRMENT The following table provides asset impairment charges for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Operating lease right-of-use asset impairment $ 233 $ — $ 1,043 $ 1,414 Property and equipment asset impairment 5,266 — 6,023 3,022 Total asset impairment $ 5,499 $ — $ 7,066 $ 4,436

Income Taxes

Income Taxes	9 Months Ended
	Nov. 02, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The quarterly provision for income taxes is based on the current estimate of the annual effective income tax rate and the tax effect of discrete items occurring during the quarter. The Company’s quarterly provision and the estimate of the annual effective tax rate are subject to significant variation due to several factors. These factors include variability in the pre-tax jurisdictional mix of earnings, changes in how the Company does business including entering into new businesses or geographies, changes in foreign currency exchange rates, changes in laws, regulations, interpretations and administrative practices, relative changes in expenses or losses for which tax benefits are not recognized and the impact of discrete items. In addition, jurisdictions where the Company anticipates an ordinary loss for the fiscal year for which the Company does not anticipate future tax benefits are excluded from the overall computation of estimated annual effective tax rate and no tax benefits are recognized in the period related to losses in such jurisdictions. The impact of these items on the effective tax rate will be greater at lower levels of pre-tax earnings. Impact of valuation allowances During the thirteen and thirty-nine weeks ended November 2, 2024, the Company did not recognize income tax benefits on $7.7 million and $22.3 million respectively, of pretax losses, primarily in Switzerland, resulting in adverse tax impacts of $1.2 million and $3.4 million, respectively. As of November 2, 2024, the Company had foreign net deferred tax assets of approximately $39.5 million, including $10.0 million, $6.1 million, and $13.1 million in China, Japan and the United Kingdom, respectively. While the Company believes that these net deferred tax assets are more-likely-than-not to be realized, it is not a certainty, as the Company continues to evaluate and respond to emerging situations. Should circumstances change, the net deferred tax assets may become subject to additional valuation allowances in the future. Additional valuation allowances would result in additional tax expense. During the thirteen and thirty-nine weeks ended October 28, 2023, the Company did not recognize income tax benefits on $20.0 million and $63.0 million of pretax losses, primarily in Switzerland, resulting in adverse tax impacts of $3.0 million and $9.6 million, respectively. As of February 3, 2024, there were approximately $7.6 million, $7.5 million, and $12.6 million of net deferred tax assets in China, Japan, and the United Kingdom, respectively. Share-based compensation Refer to Note 11, “ SHARE-BASED COMPENSATION ,” for details on income tax benefits and charges related to share-based compensation awards during the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023.

Borrowings

Borrowings	9 Months Ended
	Nov. 02, 2024
Debt Disclosure [Abstract]
Borrowings	BORROWINGS Senior Secured Notes On July 15, 2024 (the “Redemption Date”), A&F redeemed all of its outstanding 8.75% Senior Secured Notes due July 15, 2025, which had an aggregate principal amount of $214 million, at a redemption price equal to 100% of the principal amount, plus accrued and unpaid interest to, but excluding, the Redemption Date, and incurred a $0.9 million loss on extinguishment of debt, recognized in interest expense on the Condensed Consolidated Statements of Operations and Comprehensive Income. For the year-to-date period through the Redemption date, A&F Management repurchased $9.3 million in the open market and redeemed $214 million of its Senior Secured Notes and incurred a loss on extinguishment of debt of $1.1 million. As of the Redemption Date, the Senior Secured Notes were no longer deemed outstanding and interest on the Senior Secured Notes ceased to accrue. ABL Facility On August 2, 2024, A&F, as parent and a guarantor, A&F Management, as lead borrower, and certain of A&F’s direct and indirect wholly-owned subsidiaries, as additional borrowers and guarantors, entered into the Second Amendment to the Amended and Restated Credit Agreement (the “Second Amendment”), together with the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent for the lenders. The Second Amendment amends the existing Amended and Restated Credit Agreement, dated as of April 29, 2021 (the “ABL Credit Agreement”), which provided for a $400 million senior secured asset-based revolving credit facility. The Company incurred customary fees and expenses in connection with the entry into the Second Amendment. The Second Amendment amended the ABL Credit Agreement to, among other things: • increase the aggregate commitments thereunder to $500 million; • establish a $100 million sub-facility for the benefit of Abfico Netherlands Distribution B.V. (“Abfico”) and AFH Stores UK Limited (“AFH UK”) that is (i) secured by a first priority security interest in all assets (subject to specified exclusions) of each of Abfico and AFH UK, (ii) guaranteed by A&F and certain of its domestic direct and indirect wholly-owned subsidiaries, and (iii) subject to a borrowing base as described therein; • extend the maturity date from April 29, 2026 to August 2, 2029; • increase the letter of credit sub-limit from $50 million to $62.5 million; • decrease the swing line availability from $50 million to $30 million; • decrease the unused line fee from a variable rate of 25 basis points to 37.5 basis points to a flat rate of 25 basis points; and • increase pricing of the interest rate margin applicable to borrowings as follows: ◦ from 1.25% to 1.50% when average availability is greater than or equal to 50% of the Loan Cap (as defined in the Second Amendment); and ◦ from 1.50% to 1.75% when average availability is less than 50% of the Loan Cap. The ABL Facility is subject to a borrowing base, consisting primarily of inventory located in the U.S., the United Kingdom and the Netherlands, with a letter of credit sub-limit of $62.5 million, a swing line loan sub-limit of $30 million, and an accordion feature allowing A&F to increase the revolving commitment by up to $150 million subject to specified conditions. The ABL Facility is available for working capital, capital expenditures, and other general corporate purposes. As of November 2, 2024, availability under the ABL Facility was $499.6 million, net of $0.4 million in outstanding stand-by letters of credit. As the Company must maintain excess availability equal to the greater of 10% of the loan cap or $36 million under the ABL Facility, borrowing capacity available to the Company under the ABL Facility was $449.6 million as of November 2, 2024. Representations, warranties and covenants The agreements related to the ABL Facility contain various representations, warranties and restrictive covenants that, among other things and subject to specified exceptions, restrict the ability of the Company and its subsidiaries to: grant or incur liens; incur, assume or guarantee additional indebtedness; sell or otherwise dispose of assets, including capital stock of subsidiaries; make investments in certain subsidiaries; pay dividends, make distributions or redeem or repurchase capital stock; change the nature of their business; and consolidate or merge with or into, or sell substantially all of the assets of the Company or A&F Management to another entity. Certain of the agreements related to the ABL Facility also contain certain affirmative covenants, including reporting requirements such as delivery of financial statements, certificates and notices of certain events, maintaining insurance and providing additional guarantees and collateral in certain circumstances. The Company was in compliance with all debt covenants under these agreements as of November 2, 2024.

Share-Based Compensation

Share-Based Compensation	9 Months Ended
	Nov. 02, 2024
Share-Based Payment Arrangement [Abstract]
SHARE-BASED COMPENSATION	SHARE-BASED COMPENSATION Financial statement impact The following table provides share-based compensation expense and the related income tax impacts for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Share-based compensation expense $ 9,527 $ 9,684 $ 30,123 $ 29,331 Income tax benefits associated with share-based compensation expense recognized 1,287 1,080 3,805 3,163 The following table provides discrete income tax benefits and charges related to share-based compensation awards during the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Income tax discrete benefits realized for tax deductions related to the issuance of shares $ 581 $ 861 $ 17,913 $ 2,303 Income tax discrete charges realized upon cancellation of stock appreciation rights — — — (101) Total income tax discrete benefits related to share-based compensation awards $ 581 $ 861 $ 17,913 $ 2,202 The following table provides the amount of employee tax withheld by the Company upon the issuance of shares associated with restricted stock units vesting and the exercise of stock appreciation rights for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Employee tax withheld upon issuance of shares (1) $ 2,388 $ 10,310 $ 69,613 $ 29,079 (1) Classified within financing activities on the Condensed Consolidated Statements of Cash Flows. Restricted stock units The following table provides the summarized activity for restricted stock units for the thirty-nine weeks ended November 2, 2024: Service-based Restricted Performance-based Restricted Market-based Restricted Number of Weighted- Number of Weighted- Number of Weighted- Unvested at February 3, 2024 1,886,085 $ 27.12 521,212 $ 30.03 260,619 $ 43.90 Granted 236,530 123.01 53,775 120.56 26,895 180.71 Adjustments for performance achievement — — 150,446 32.10 75,227 50.34 Vested (866,119) 25.03 (300,892) 32.10 (150,454) 50.34 Forfeited (75,993) 35.65 — — — — Unvested at November 2, 2024 (1) 1,180,503 $ 47.41 424,541 $ 40.76 212,287 $ 58.95 (1) Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can be achieved from zero up to 200% of their target vesting amount. The following table provides the unrecognized compensation cost and the remaining weighted-average period over which these costs are expected to be recognized for restricted stock units as of November 2, 2024: Service-based Restricted Performance-based Restricted Market-based Restricted Unrecognized compensation cost (in thousands) $ 41,966 $ 16,647 $ 6,163 Remaining weighted-average period cost is expected to be recognized (years) 1.1 1.1 1.1 The following table provides additional information pertaining to restricted stock units for the thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 Service-based restricted stock units: Total grant date fair value of awards granted $ 29,096 $ 26,237 Total grant date fair value of awards vested 21,679 23,051 Performance-based restricted stock units: Total grant date fair value of awards granted 6,483 6,300 Total grant date fair value of awards vested 9,659 — Market-based restricted stock units: Total grant date fair value of awards granted 4,860 4,576 Total grant date fair value of awards vested 7,574 16,040 The following table provides the weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirty-Nine Weeks Ended November 2, 2024 October 28, 2023 Grant date market price $ 120.56 $ 28.36 Fair value 180.71 41.20 Price volatility 59 % 63 % Expected term (years) 2.9 2.9 Risk-free interest rate 4.3 % 4.6 % Dividend yield — — Average volatility of peer companies 51.8 66.0 Average correlation coefficient of peer companies 0.4866 0.5295 Stock appreciation rights The following table provides the summarized stock appreciation rights activity for the thirty-nine weeks ended November 2, 2024: Number of Weighted-Average Aggregate Intrinsic Value (in thousands) Weighted-Average Outstanding at February 3, 2024 25,600 $ 29.29 Exercised (25,600) 29.29 Forfeited or expired — — Outstanding at November 2, 2024 — $ — $ — 0.0 Stock appreciation rights exercisable at November 2, 2024 — $ — $ — 0.0 As of November 2, 2024, no stock appreciation rights remain outstanding. The following table provides additional information pertaining to stock appreciation rights exercised during the thirty-nine weeks ended November 2, 2024 and October 28, 2023: (in thousands) November 2, 2024 October 28, 2023 Total grant date fair value of awards exercised $ 267 $ 1,292

Derivative Instruments

Derivative Instruments	9 Months Ended
	Nov. 02, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	DERIVATIVE INSTRUMENTS The Company is exposed to risks associated with changes in foreign currency exchange rates and uses derivative instruments, primarily forward contracts, to manage the financial impacts of these exposures. The Company does not use forward contracts to engage in currency speculation and does not enter into derivative financial instruments for trading purposes. The Company uses derivative instruments, primarily foreign currency exchange forward contracts designated as cash flow hedges, to hedge the foreign currency exchange rate exposure associated with forecasted foreign-currency-denominated intercompany inventory sales to foreign subsidiaries and the related settlement of the foreign-currency-denominated intercompany receivables. Fluctuations in foreign currency exchange rates will either increase or decrease the Company’s intercompany equivalent cash flows and affect the Company’s U.S. dollar earnings. Gains or losses on the foreign currency exchange forward contracts that are used to hedge these exposures are expected to partially offset this variability. Foreign currency exchange forward contracts represent agreements to exchange the currency of one country for the currency of another country at an agreed upon settlement date. These foreign currency exchange forward contracts typically have a maximum term of twelve months. The sale of the inventory to the Company’s customers will result in the reclassification of related derivative gains and losses that are reported in AOCL into earnings. The Company also uses foreign currency exchange forward contracts to hedge certain foreign-currency-denominated net monetary assets/liabilities. Examples of monetary assets/liabilities include cash balances, receivables and payables. Fluctuations in foreign currency exchange rates result in transaction gains or losses being recorded in earnings, as GAAP requires that monetary assets/liabilities be remeasured at the spot exchange rate at quarter-end and upon settlement. The Company has chosen not to apply hedge accounting to these instruments because there are no anticipated differences in the timing of gain or loss recognition on the hedging instruments and the hedged items. As of November 2, 2024, the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany transactions: (in thousands) Notional Amount (1) Euro $ 69,300 British pound 84,134 Canadian dollar 28,480 (1) Amounts reported are the U.S. dollar notional amounts outstanding as of November 2, 2024. The fair value of derivative instruments is determined using quoted market prices of the same or similar instruments, adjusted for counterparty risk. The following table provides the location and amounts of derivative fair values of foreign currency exchange forward contracts on the Condensed Consolidated Balance Sheets as of November 2, 2024 and February 3, 2024: (in thousands) Location November 2, 2024 February 3, 2024 Location November 2, 2024 February 3, 2024 Derivatives designated as cash flow hedging instruments Other current assets $ 2,143 $ 1,090 Accrued expenses $ 419 $ 539 Derivatives not designated as hedging instruments Other current assets — 2 Accrued expenses — — Total $ 2,143 $ 1,092 $ 419 $ 539 The following table provides information pertaining to derivative gains or losses from foreign currency exchange forward contracts designated as cash flow hedging instruments for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Gain recognized in AOCL (1) $ 1,162 $ 7,151 $ 1,604 $ 7,202 (Loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization (2) (351) (326) 659 (2,940) (1) Amount represents the change in fair value of derivative instruments. (2) Amount represents (loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization. Substantially all of the unrealized gain will be recognized in costs of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income over the next twelve months. The following table provides additional information pertaining to derivative gains or losses from foreign currency exchange forward contracts not designated as hedging instruments for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Gain (loss) recognized in other operating (income) loss, net $ 11 $ 2,193 $ 454 $ (239)

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Nov. 02, 2024
Equity [Abstract]
ACCUMULATED OTHER COMPREHENSIVE LOSS	r the thirteen and thirty-nine weeks ended November 2, 2024: Thirteen Weeks Ended November 2, 2024 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at August 3, 2024 $ (134,928) $ (63) $ (134,991) Other comprehensive income before reclassifications 84 1,162 1,246 Reclassified loss from AOCL (1) — 351 351 Tax effect — (52) (52) Other comprehensive income after reclassifications 84 1,461 1,545 Ending balance at November 2, 2024 $ (134,844) $ 1,398 $ (133,446) Thirty-Nine Weeks Ended November 2, 2024 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at February 3, 2024 $ (136,532) $ 564 $ (135,968) Other comprehensive income before reclassifications 1,688 1,604 3,292 Reclassified gain from AOCL (1) — (659) (659) Tax effect — (111) (111) Other comprehensive income after reclassifications 1,688 834 2,522 Ending balance at November 2, 2024 $ (134,844) $ 1,398 $ (133,446) (1) Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income. The following tables provide activity in AOCL for the thirteen and thirty-nine weeks ended October 28, 2023: Thirteen Weeks Ended October 28, 2023 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at July 29, 2023 $ (136,178) $ (2,227) $ (138,405) Other comprehensive (loss) income before reclassifications (5,042) 7,151 2,109 Reclassified loss from AOCL (1) — 326 326 Tax effect — (218) (218) Other comprehensive (loss) income after reclassifications (5,042) 7,259 2,217 Ending balance at October 28, 2023 $ (141,220) $ 5,032 $ (136,188) Thirty-Nine Weeks Ended October 28, 2023 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 28, 2023 $ (132,653) $ (4,874) $ (137,527) Other comprehensive (loss) income before reclassifications (8,567) 7,202 (1,365) Reclassified loss from AOCL (1) — 2,940 2,940 Tax effect — (236) (236) Other comprehensive (loss) income after reclassifications (8,567) 9,906 1,339 Ending balance at October 28, 2023 $ (141,220) $ 5,032 $ (136,188) (1) Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income.

Segment Reporting

Segment Reporting	9 Months Ended
	Nov. 02, 2024
Segment Reporting [Abstract]
SEGMENT REPORTING	SEGMENT REPORTING The Company’s reportable segments are based on the financial information the CODM uses to allocate resources and assess performance of its business. The Company manages its business on a geographic basis, consisting of three reportable segments: Americas; EMEA; and APAC. Corporate functions and other income and expenses are evaluated on a consolidated basis and are not allocated to the Company’s segments, and therefore are included as a reconciling item between segment and total operating income. The Americas reportable segment includes the results of operations in North America and South America. The EMEA reportable segment includes the results of operations in Europe, the Middle East and Africa. The APAC reportable segment includes the results of operations in the Asia-Pacific region, including Asia and Oceania. Intersegment sales and transfers are recorded at cost and are treated as a transfer of inventory. All intercompany revenues are eliminated in consolidation and are not reviewed when evaluating segment performance. The group comprised of the Company’s (i) Chief Executive Officer and (ii) Chief Financial Officer and Chief Operating Officer functioned as the Company’s CODM as of November 2, 2024. The Company’s CODM manages business operations and evaluates the performance of each segment based on the net sales and operating income (loss) of the segment. Net sales by segment are presented by attributing revenues to a physical store location or geographical region that fulfills the order. Operating income for each segment includes net sales to third parties, related cost of sales and operating expenses directly attributed to the segment. Corporate/other expenses include expenses incurred that are not directly attributed to a reportable segment and primarily relate to corporate or global functions such as design, sourcing, brand management, corporate strategy, information technology, finance, treasury, legal, human resources, and other corporate support services, as well as certain globally managed components of the planning, merchandising, and marketing functions. The Company reports inventories by segment as that information is used by the CODM in determining allocation of resources to the segments. The Company does not report its other assets by segment as that information is not used by the CODM in assessing segment performance or allocating resources. The following tables provide the Company’s segment information as of November 2, 2024 and February 3, 2024, and for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Net Sales Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Americas $ 986,449 $ 867,566 $ 2,707,794 $ 2,264,415 EMEA 181,592 157,976 546,052 468,045 APAC 40,925 30,889 109,824 95,310 Segment total $ 1,208,966 $ 1,056,431 $ 3,363,670 $ 2,827,770 Operating Income (Loss) Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Operating Income (loss) Americas $ 304,542 $ 257,440 $ 832,009 $ 590,948 EMEA 21,708 20,795 84,249 49,170 APAC (4,181) (3,261) (7,748) (6,272) Segment total $ 322,069 $ 274,974 $ 908,510 $ 633,846 Operating (loss) income not attributed to segments: Stores and distribution expense (4,671) (3,202) (13,044) (8,205) Marketing, general and administrative expense (139,691) (132,496) (414,310) (368,099) Other operating income (loss), net 1,575 (1,256) 3,600 4,328 Total operating income $ 179,282 $ 138,020 $ 484,756 $ 261,870 Assets (in thousands) November 2, 2024 February 3, 2024 Inventories Americas $ 569,713 $ 372,371 EMEA 98,842 77,125 APAC 24,041 19,970 Total inventories $ 692,596 $ 469,466 Assets not attributed to segments 2,577,276 2,504,767 Total assets $ 3,269,872 $ 2,974,233 Brand Information The following table provides additional disaggregated revenue information, which is categorized by brand, for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Abercrombie (1) $ 629,835 $ 547,728 $ 1,783,764 $ 1,446,483 Hollister (2) 579,131 508,703 1,579,906 1,381,287 Total $ 1,208,966 $ 1,056,431 $ 3,363,670 $ 2,827,770

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Pay vs Performance Disclosure
Net Income (Loss) Attributable to Parent	$ 131,979	$ 96,211	$ 378,997	$ 169,676

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Nov. 02, 2024 shares	Nov. 02, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted		false
Rule 10b5-1 Arrangement Terminated		false
Non-Rule 10b5-1 Arrangement Terminated		false
FranHorowitz [Member]
Trading Arrangements, by Individual
Name	Fran Horowitz
Title	Chief Executive Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 30, 2024
Aggregate Available	250,000	250,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Nov. 02, 2024
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its financial position, results of operations and cash flows. The Company has interests in Emirati and Kuwaiti business ventures with Majid al Futtaim Lifestyle L.L.C. (“MAF”) and in a United States of America (the “U.S.”) business venture with Dixar L.L.C. (“Dixar”), each of which meets the definition of a variable interest entity (“VIE”). The purpose of the business ventures with MAF is to operate stores in the United Arab Emirates and Kuwait, and the purpose of the business venture with Dixar is to hold the intellectual property related to the Social Tourist brand. The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the operating results, assets and liabilities of these VIEs, with the noncontrolling interests’ (“NCI”) portions of net income presented as net income attributable to NCI on the Condensed Consolidated Statements of Operations and Comprehensive Income and the NCI portion of stockholders’ equity presented as NCI on the Condensed Consolidated Balance Sheets.
Fiscal Period, Policy [Policy Text Block]	Fiscal year The Company’s fiscal year ends on the Saturday closest to January 31. This typically results in a fifty-two week year, but occasionally gives rise to an additional week, resulting in a fifty-three week year. Fiscal years are designated in the Condensed Consolidated Financial Statements and notes, as well as the remainder of this Quarterly Report on Form 10-Q, by the calendar year in which the fiscal year commences. All references herein to the Company’s fiscal years are as follows: Fiscal year Year ended/ending Number of weeks Fiscal 2023 February 3, 2024 53 Fiscal 2024 February 1, 2025 52 Fiscal 2025 January 31, 2026 52
New Accounting Pronouncements, Policy	Recent accounting pronouncements The Company reviews recent accounting pronouncements on a quarterly basis and has excluded discussion of those not applicable to the Company and those that did not have, or are not expected to have, a material impact on the Company’s consolidated financial statements. The following table provides a brief description of certain accounting pronouncements the Company has not yet adopted and that could affect the Company’s financial statements. Accounting Standards Update (ASU) Description Effect on the financial statements or other significant matters ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures The update modifies the disclosure/presentation requirements of reportable segments. The amendments in the update require the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”) and included within each reported measure of segment profit and loss. The amendments also require disclosure of all other segment items by reportable segment and a description of its composition. Additionally, the amendments require disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. This update is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company's consolidated financial statements. ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures The update requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The update will be effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company's consolidated financial statements. ASU 2024-03 - Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses The update requires a disaggregated disclosure of income statement expenses. The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The update is effective for fiscal years beginning after December 15, 2026 and interim period periods for fiscal years beginning after December 15, 2027. Early adoption is permitted. Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company’s consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Nov. 02, 2024
Accounting Policies [Abstract]
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]	Recent accounting pronouncements The Company reviews recent accounting pronouncements on a quarterly basis and has excluded discussion of those not applicable to the Company and those that did not have, or are not expected to have, a material impact on the Company’s consolidated financial statements. The following table provides a brief description of certain accounting pronouncements the Company has not yet adopted and that could affect the Company’s financial statements. Accounting Standards Update (ASU) Description Effect on the financial statements or other significant matters ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures The update modifies the disclosure/presentation requirements of reportable segments. The amendments in the update require the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”) and included within each reported measure of segment profit and loss. The amendments also require disclosure of all other segment items by reportable segment and a description of its composition. Additionally, the amendments require disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. This update is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company's consolidated financial statements. ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures The update requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The update will be effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company's consolidated financial statements. ASU 2024-03 - Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses The update requires a disaggregated disclosure of income statement expenses. The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The update is effective for fiscal years beginning after December 15, 2026 and interim period periods for fiscal years beginning after December 15, 2027. Early adoption is permitted. Other than the new disclosure requirements, the adoption of this guidance will not have a significant impact on the Company’s consolidated financial statements.
Reconciliation of Cash and Equivalents to Restricted cash and Equivalents [Table Text Block]	Condensed Consolidated Statements of Cash Flows reconciliation The following table provides a reconciliation of cash and equivalents and restricted cash and equivalents to the amounts shown on the Condensed Consolidated Statements of Cash Flows: (in thousands) Location November 2, 2024 February 3, 2024 October 28, 2023 January 28, 2023 Cash and equivalents Cash and equivalents $ 683,089 $ 900,884 $ 649,489 $ 517,602 Restricted cash and equivalents Other assets 7,908 8,801 8,639 9,967 Cash and equivalents and restricted cash and equivalents $ 690,997 $ 909,685 $ 658,128 $ 527,569
Supplier Finance Program	The following table provides activity in the SCF program for the thirty-nine weeks ended November 2, 2024: Thirty-Nine Weeks Ended (in thousands) November 2, 2024 Confirmed obligations outstanding at the beginning of the period $ 72,376 Invoices confirmed during the period 326,109 Confirmed invoices paid during the period (289,164) Confirmed obligations outstanding at the end of the period $ 109,321

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Nov. 02, 2024
Disaggregation of Revenue [Abstract]
Deferred Revenue, by Arrangement, Disclosure [Table Text Block]	The following table details certain contract liabilities representing unearned revenue as of November 2, 2024, February 3, 2024, October 28, 2023 and January 28, 2023: (in thousands) November 2, 2024 February 3, 2024 October 28, 2023 January 28, 2023 Gift card liability (1) $ 39,096 $ 41,144 $ 36,506 $ 39,235 Loyalty programs liability 30,648 27,937 24,521 25,640 (1) Includes $17.7 million and $15.5 million of revenue recognized during the thirty-nine weeks ended November 2, 2024 and October 28, 2023, respectively, that was included in the gift card liability at the beginning of February 3, 2024 and January 28, 2023, respectively.
Disaggregation of Revenue	The following table details recognized revenue associated with the Company’s gift card program and loyalty programs for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Revenue associated with gift card redemptions and gift card breakage $ 32,680 $ 24,741 $ 96,172 $ 73,391 Revenue associated with reward redemptions and breakage related to the Company’s loyalty programs 16,697 13,710 45,367 37,628

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Table)	9 Months Ended
	Nov. 02, 2024
Earnings Per Share [Abstract]
Schedule of Weighted Average Number of Shares	additional information pertaining to net income per share attributable to A&F for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Shares of Common Stock issued 103,300 103,300 103,300 103,300 Weighted-average treasury shares (52,349) (52,796) (52,270) (53,162) Weighted-average — basic shares 50,951 50,504 51,030 50,138 Dilutive effect of share-based compensation awards 1,918 2,120 2,111 2,016 Weighted-average — diluted shares 52,869 52,624 53,141 52,154 Anti-dilutive shares (1) 250 445 329 609 (1) Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieved from zero up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Nov. 02, 2024
Fair Value Disclosures [Abstract]
Company's Assets and Liabilities Measured at Fair Value	The following table provides the three levels of the hierarchy and the distribution of the Company’s assets measured at fair value on a recurring basis, as of November 2, 2024 and February 3, 2024: Assets and Liabilities at Fair Value as of November 2, 2024 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 149,605 $ 42,209 $ — $ 191,814 Marketable securities (2) — 55,790 — 55,790 Derivative instruments (3) — 2,143 — 2,143 Rabbi Trust assets (4) 1,164 53,553 — 54,717 Restricted cash equivalents (1) 3,317 1,480 — 4,797 Total assets $ 154,086 $ 155,175 $ — $ 309,261 Liabilities: Derivative instruments (3) $ — $ 419 $ — $ 419 Total liabilities $ — $ 419 $ — $ 419 Assets and Liabilities at Fair Value as of February 3, 2024 (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents (1) $ 349,174 $ 26,975 $ — $ 376,149 Derivative instruments (3) — 1,092 — 1,092 Rabbi Trust assets (4) 1,164 52,521 — 53,685 Restricted cash equivalents (1) 4,282 1,420 — 5,702 Total assets $ 354,620 $ 82,008 $ — $ 436,628 Liabilities: Derivative instruments (3) $ — $ 539 $ — $ 539 Total liabilities $ — $ 539 $ — $ 539 (1) Level 1 assets consisted of investments in money market funds and U.S. treasury bills. Level 2 assets consisted of time deposits with original maturities of less than three months. (2) Level 2 assets consisted of time deposits with original maturities greater than three months, but less than one year. (3) Level 2 assets and liabilities consisted primarily of foreign currency exchange forward contracts. (4)

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Nov. 02, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	property and equipment, net as of November 2, 2024 and February 3, 2024: (in thousands) November 2, 2024 February 3, 2024 Property and equipment, at cost $ 2,602,101 $ 2,509,184 Less: Accumulated depreciation and amortization (2,031,661) (1,971,151) Property and equipment, net $ 570,440 $ 538,033 R efer to Note 8, “ ASSET IMPAIRMENT ,” for details related to property and equipment impairment charges incurred during the thirteen and thirty-nine ended November 2, 2024 and October 28, 2023.

Leases (Tables)

Leases (Tables)	9 Months Ended
	Nov. 02, 2024
Leases [Abstract]
Lease, Cost [Table Text Block]	The following table provides a summary of the Company’s operating lease costs for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Single lease cost (1) $ 69,167 $ 63,177 $ 193,310 $ 184,172 Variable lease cost (2) 45,715 32,332 137,081 119,809 Operating lease right-of-use asset impairment (3) 233 — 1,043 1,414 Sublease income (1,003) (979) (2,973) (2,959) Total operating lease cost $ 114,112 $ 94,530 $ 328,461 $ 302,436 (1) Includes amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities. (2) Includes variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs. (3) Refer to Note 8, “ ASSET IMPAIRMENT ,” for details related to operating lease right-of-use asset impairment charges.

Asset Impairment (Tables)

Asset Impairment (Tables)	9 Months Ended
	Nov. 02, 2024
Asset Impairment [Abstract]
Impaired Assets to be Disposed of by Method Other than Sale [Table Text Block]	asset impairment charges for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Operating lease right-of-use asset impairment $ 233 $ — $ 1,043 $ 1,414 Property and equipment asset impairment 5,266 — 6,023 3,022 Total asset impairment $ 5,499 $ — $ 7,066 $ 4,436

Share-Based Compensation (Table

Share-Based Compensation (Tables)	9 Months Ended
	Nov. 02, 2024
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	The following table provides share-based compensation expense and the related income tax impacts for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Share-based compensation expense $ 9,527 $ 9,684 $ 30,123 $ 29,331 Income tax benefits associated with share-based compensation expense recognized 1,287 1,080 3,805 3,163
Share-based Payment Arrangement, Discrete Tax Benefit (Charge) [Table Text Block]	The following table provides discrete income tax benefits and charges related to share-based compensation awards during the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Income tax discrete benefits realized for tax deductions related to the issuance of shares $ 581 $ 861 $ 17,913 $ 2,303 Income tax discrete charges realized upon cancellation of stock appreciation rights — — — (101) Total income tax discrete benefits related to share-based compensation awards $ 581 $ 861 $ 17,913 $ 2,202
Employee tax withheld by company for share-based compensation	The following table provides the amount of employee tax withheld by the Company upon the issuance of shares associated with restricted stock units vesting and the exercise of stock appreciation rights for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Employee tax withheld upon issuance of shares (1) $ 2,388 $ 10,310 $ 69,613 $ 29,079 (1) Classified within financing activities on the Condensed Consolidated Statements of Cash Flows.
Schedule of Restricted Stock Unit Activity	The following table provides the summarized activity for restricted stock units for the thirty-nine weeks ended November 2, 2024: Service-based Restricted Performance-based Restricted Market-based Restricted Number of Weighted- Number of Weighted- Number of Weighted- Unvested at February 3, 2024 1,886,085 $ 27.12 521,212 $ 30.03 260,619 $ 43.90 Granted 236,530 123.01 53,775 120.56 26,895 180.71 Adjustments for performance achievement — — 150,446 32.10 75,227 50.34 Vested (866,119) 25.03 (300,892) 32.10 (150,454) 50.34 Forfeited (75,993) 35.65 — — — — Unvested at November 2, 2024 (1) 1,180,503 $ 47.41 424,541 $ 40.76 212,287 $ 58.95 (1) Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can be achieved from zero up to 200% of their target vesting amount.
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award	The following table provides the unrecognized compensation cost and the remaining weighted-average period over which these costs are expected to be recognized for restricted stock units as of November 2, 2024: Service-based Restricted Performance-based Restricted Market-based Restricted Unrecognized compensation cost (in thousands) $ 41,966 $ 16,647 $ 6,163 Remaining weighted-average period cost is expected to be recognized (years) 1.1 1.1 1.1
Schedule of Stock Appreciation Rights Activity	The following table provides the summarized stock appreciation rights activity for the thirty-nine weeks ended November 2, 2024: Number of Weighted-Average Aggregate Intrinsic Value (in thousands) Weighted-Average Outstanding at February 3, 2024 25,600 $ 29.29 Exercised (25,600) 29.29 Forfeited or expired — — Outstanding at November 2, 2024 — $ — $ — 0.0 Stock appreciation rights exercisable at November 2, 2024 — $ — $ — 0.0 As of November 2, 2024, no stock appreciation rights remain outstanding. The following table provides additional information pertaining to stock appreciation rights exercised during the thirty-nine weeks ended November 2, 2024 and October 28, 2023: (in thousands) November 2, 2024 October 28, 2023 Total grant date fair value of awards exercised $ 267 $ 1,292
Market-based restricted stock units [Member]
Schedule of Weighted-Average Estimated Fair Value and Assumptions of Restricted Stock Units with Market Vesting Conditions	additional information pertaining to restricted stock units for the thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 Service-based restricted stock units: Total grant date fair value of awards granted $ 29,096 $ 26,237 Total grant date fair value of awards vested 21,679 23,051 Performance-based restricted stock units: Total grant date fair value of awards granted 6,483 6,300 Total grant date fair value of awards vested 9,659 — Market-based restricted stock units: Total grant date fair value of awards granted 4,860 4,576 Total grant date fair value of awards vested 7,574 16,040 The following table provides the weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirty-Nine Weeks Ended November 2, 2024 October 28, 2023 Grant date market price $ 120.56 $ 28.36 Fair value 180.71 41.20 Price volatility 59 % 63 % Expected term (years) 2.9 2.9 Risk-free interest rate 4.3 % 4.6 % Dividend yield — — Average volatility of peer companies 51.8 66.0 Average correlation coefficient of peer companies 0.4866 0.5295

Derivative Instruments (Tables)

Derivative Instruments (Tables)	9 Months Ended
	Nov. 02, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Outstanding Foreign Exchange Forward Contracts	As of November 2, 2024, the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany transactions: (in thousands) Notional Amount (1) Euro $ 69,300 British pound 84,134 Canadian dollar 28,480 (1) Amounts reported are the U.S. dollar notional amounts outstanding as of November 2, 2024.
Location and Amounts of Derivative Fair Values on the Condensed Consolidated Balance Sheets	The fair value of derivative instruments is determined using quoted market prices of the same or similar instruments, adjusted for counterparty risk. The following table provides the location and amounts of derivative fair values of foreign currency exchange forward contracts on the Condensed Consolidated Balance Sheets as of November 2, 2024 and February 3, 2024: (in thousands) Location November 2, 2024 February 3, 2024 Location November 2, 2024 February 3, 2024 Derivatives designated as cash flow hedging instruments Other current assets $ 2,143 $ 1,090 Accrued expenses $ 419 $ 539 Derivatives not designated as hedging instruments Other current assets — 2 Accrued expenses — — Total $ 2,143 $ 1,092 $ 419 $ 539
Location and Amounts of Derivative Gains and Losses on the Condensed Consolidated Statements of Operations and Comprehensive Loss	information pertaining to derivative gains or losses from foreign currency exchange forward contracts designated as cash flow hedging instruments for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Gain recognized in AOCL (1) $ 1,162 $ 7,151 $ 1,604 $ 7,202 (Loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization (2) (351) (326) 659 (2,940) (1) Amount represents the change in fair value of derivative instruments. (2) Amount represents (loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization. Substantially all of the unrealized gain will be recognized in costs of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income over the next twelve months. The following table provides additional information pertaining to derivative gains or losses from foreign currency exchange forward contracts not designated as hedging instruments for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Gain (loss) recognized in other operating (income) loss, net $ 11 $ 2,193 $ 454 $ (239)

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Nov. 02, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Loss	The following tables provide activity in AOCL for the thirteen and thirty-nine weeks ended November 2, 2024: Thirteen Weeks Ended November 2, 2024 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at August 3, 2024 $ (134,928) $ (63) $ (134,991) Other comprehensive income before reclassifications 84 1,162 1,246 Reclassified loss from AOCL (1) — 351 351 Tax effect — (52) (52) Other comprehensive income after reclassifications 84 1,461 1,545 Ending balance at November 2, 2024 $ (134,844) $ 1,398 $ (133,446) Thirty-Nine Weeks Ended November 2, 2024 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at February 3, 2024 $ (136,532) $ 564 $ (135,968) Other comprehensive income before reclassifications 1,688 1,604 3,292 Reclassified gain from AOCL (1) — (659) (659) Tax effect — (111) (111) Other comprehensive income after reclassifications 1,688 834 2,522 Ending balance at November 2, 2024 $ (134,844) $ 1,398 $ (133,446) (1) Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income. The following tables provide activity in AOCL for the thirteen and thirty-nine weeks ended October 28, 2023: Thirteen Weeks Ended October 28, 2023 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at July 29, 2023 $ (136,178) $ (2,227) $ (138,405) Other comprehensive (loss) income before reclassifications (5,042) 7,151 2,109 Reclassified loss from AOCL (1) — 326 326 Tax effect — (218) (218) Other comprehensive (loss) income after reclassifications (5,042) 7,259 2,217 Ending balance at October 28, 2023 $ (141,220) $ 5,032 $ (136,188) Thirty-Nine Weeks Ended October 28, 2023 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 28, 2023 $ (132,653) $ (4,874) $ (137,527) Other comprehensive (loss) income before reclassifications (8,567) 7,202 (1,365) Reclassified loss from AOCL (1) — 2,940 2,940 Tax effect — (236) (236) Other comprehensive (loss) income after reclassifications (8,567) 9,906 1,339 Ending balance at October 28, 2023 $ (141,220) $ 5,032 $ (136,188) (1) Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income.

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Nov. 02, 2024
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	The following tables provide the Company’s segment information as of November 2, 2024 and February 3, 2024, and for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Net Sales Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Americas $ 986,449 $ 867,566 $ 2,707,794 $ 2,264,415 EMEA 181,592 157,976 546,052 468,045 APAC 40,925 30,889 109,824 95,310 Segment total $ 1,208,966 $ 1,056,431 $ 3,363,670 $ 2,827,770
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	Operating Income (Loss) Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Operating Income (loss) Americas $ 304,542 $ 257,440 $ 832,009 $ 590,948 EMEA 21,708 20,795 84,249 49,170 APAC (4,181) (3,261) (7,748) (6,272) Segment total $ 322,069 $ 274,974 $ 908,510 $ 633,846 Operating (loss) income not attributed to segments: Stores and distribution expense (4,671) (3,202) (13,044) (8,205) Marketing, general and administrative expense (139,691) (132,496) (414,310) (368,099) Other operating income (loss), net 1,575 (1,256) 3,600 4,328 Total operating income $ 179,282 $ 138,020 $ 484,756 $ 261,870
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	Assets (in thousands) November 2, 2024 February 3, 2024 Inventories Americas $ 569,713 $ 372,371 EMEA 98,842 77,125 APAC 24,041 19,970 Total inventories $ 692,596 $ 469,466 Assets not attributed to segments 2,577,276 2,504,767 Total assets $ 3,269,872 $ 2,974,233
Revenue from External Customers by Operating Segment [Table Text Block]	Brand Information The following table provides additional disaggregated revenue information, which is categorized by brand, for the thirteen and thirty-nine weeks ended November 2, 2024 and October 28, 2023: Thirteen Weeks Ended Thirty-Nine Weeks Ended (in thousands) November 2, 2024 October 28, 2023 November 2, 2024 October 28, 2023 Abercrombie (1) $ 629,835 $ 547,728 $ 1,783,764 $ 1,446,483 Hollister (2) 579,131 508,703 1,579,906 1,381,287 Total $ 1,208,966 $ 1,056,431 $ 3,363,670 $ 2,827,770 (1) Includes Abercrombie & Fitch and abercrombie kids. (2) Includes Hollister and Gilly Hicks

Summary of Significant Accoun_4

Summary of Significant Accounting Policies Condensed Consolidated Statements of Cash Flows reconciliation (Details) - USD ($) $ in Thousands	Nov. 02, 2024	Feb. 03, 2024	Oct. 28, 2023	Jan. 28, 2023
Condensed Statements of Cash Flows reconciliation [Abstract]
Cash and equivalents	$ 683,089	$ 900,884	$ 649,489	$ 517,602
Restricted Cash and Cash Equivalents	7,908	8,801	8,639	9,967
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 690,997	$ 909,685	$ 658,128	$ 527,569

Summary of Significant Accoun_5

Summary of Significant Accounting Policies Supplier Chain Financing (Details) - USD ($) $ in Thousands	9 Months Ended
	Nov. 02, 2024	Feb. 03, 2024
Supplier Finance Program, Obligation [Roll Forward]
Supplier Finance Program, Payment Timing, Period	75 days
Supplier Finance Program Obligation Current	$ 109,300	$ 72,400
Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]	Accounts Payable, Current	Accounts Payable, Current
SupplierFinanceProgram
Supplier Finance Program, Obligation [Roll Forward]
Supplier Finance Program, Obligation, Addition	$ 326,109
Supplier Finance Program, Obligation, Settlement	(289,164)
Supplier Finance Program Obligation Current	$ 109,321	$ 72,376

Summary of Significant Accoun_6

Summary of Significant Accounting Policies Recent Accounting Pronouncements (Details)	9 Months Ended
	Nov. 02, 2024
Recent Accounting Pronouncements [Abstract]
Maximum Length Of Time Inventory Sales Hedged	12 months

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023	Feb. 03, 2024		Jan. 28, 2023
Gift Card
Deferred Revenue Arrangement [Line Items]
Contract with Customer, Liability, Current	$ 39,096	$ 36,506	$ 39,096	$ 36,506	$ 41,144	[1]	$ 39,235	[1]
Contract with Customer, Liability, Revenue Recognized			17,700	15,500
Revenue from Contract with Customer	32,680	24,741	96,172	73,391
Royalty
Deferred Revenue Arrangement [Line Items]
Contract with Customer, Liability, Current	30,648	24,521	30,648	24,521	$ 27,937		$ 25,640
Revenue from Contract with Customer	$ 16,697	$ 13,710	$ 45,367	$ 37,628
[1] Includes $17.7 million and $15.5 million of revenue recognized during the thirty-nine weeks ended November 2, 2024 and October 28, 2023, respectively, that was included in the gift card liability at the beginning of February 3, 2024 and January 28, 2023, respectively.

Net Income (Loss) Per Share (De

Net Income (Loss) Per Share (Details) - shares shares in Thousands		3 Months Ended		9 Months Ended
		Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Weighted Average Shares Outstanding And Anti Dilutive Shares [Abstract]
Shares of Common Stock issued		103,300	103,300	103,300	103,300
Weighted-average treasury shares		(52,349)	(52,796)	(52,270)	(53,162)
Weighted-average — basic shares		50,951	50,504	51,030	50,138
Dilutive effect of share-based compensation awards		1,918	2,120	2,111	2,016
Weighted-average — diluted shares		52,869	52,624	53,141	52,154
Anti-dilutive shares (1)	[1]	250	445	329	609
[1] Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieved from zero up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.

Fair Value (Assets and Liabilit

Fair Value (Assets and Liabilities at Fair Value) (Details) - USD ($) $ in Thousands		Nov. 02, 2024	Jul. 15, 2024	Feb. 03, 2024
Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	[1]	$ 191,814		$ 376,149
Marketable Securities	[2]	55,790
Derivative instruments (2)	[3]	2,143		1,092
Restricted Investments, Noncurrent	[4]	54,717		53,685
Restricted Cash Equivalents, Noncurrent	[1]	4,797		5,702
Total assets		309,261		436,628
Liabilities, Fair Value Disclosure [Abstract]
Derivative Liability	[3]	419		539
Total liabilities		419		539
Level 1 | Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	[1]	149,605		349,174
Marketable Securities	[2]	0
Derivative instruments (2)	[3]	0		0
Restricted Investments, Noncurrent	[4]	1,164		1,164
Restricted Cash Equivalents, Noncurrent	[1]	3,317		4,282
Total assets		154,086		354,620
Liabilities, Fair Value Disclosure [Abstract]
Derivative Liability	[3]	0		0
Total liabilities		0		0
Level 2 | Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	[1]	42,209		26,975
Marketable Securities	[2]	55,790
Derivative instruments (2)		2,143		1,092	[3]
Restricted Investments, Noncurrent	[4]	53,553		52,521
Restricted Cash Equivalents, Noncurrent	[1]	1,480		1,420
Total assets		155,175		82,008
Liabilities, Fair Value Disclosure [Abstract]
Derivative Liability	[3]	419		539
Total liabilities		419		539
Level 3 | Fair Value, Recurring [Member]
Assets, Fair Value Disclosure [Abstract]
Cash and Cash Equivalents, Fair Value Disclosure	[1]	0		0
Marketable Securities	[2]	0
Derivative instruments (2)	[3]	0		0
Restricted Investments, Noncurrent	[4]	0		0
Restricted Cash Equivalents, Noncurrent	[1]	0		0
Total assets		0		0
Liabilities, Fair Value Disclosure [Abstract]
Derivative Liability	[3]	0		0
Total liabilities		0		$ 0
Senior Notes [Member]
Liabilities, Fair Value Disclosure [Abstract]
Long-Term Debt, Gross		$ 0
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate			8.75%
[1] (1) Level 2 assets consisted of time deposits with original maturities greater than three months, but less than one year. (3) Level 2 assets and liabilities consisted primarily of foreign currency exchange forward contracts. Level 1 assets consisted of investments in money market funds. Level 2 assets consisted of trust-owned life insurance policies.

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023	Feb. 03, 2024
Property, Plant and Equipment [Line Items]
Property and equipment, at cost	$ 2,602,101		$ 2,602,101		$ 2,509,184
Less: Accumulated depreciation and amortization	(2,031,661)		(2,031,661)		(1,971,151)
Property and equipment, net	570,440		570,440		$ 538,033
Property and equipment asset impairment	5,266	$ 0	6,023	$ 3,022
Asset Impairment Charges	$ 5,499	$ 0	$ 7,066	$ 4,436

Leases (Details)

Leases (Details) - USD ($) $ in Thousands		3 Months Ended				9 Months Ended
		Nov. 02, 2024		Oct. 28, 2023		Nov. 02, 2024		Oct. 28, 2023
Leases [Abstract]
Single lease cost	[1]	$ 69,167		$ 63,177		$ 193,310		$ 184,172
Variable lease cost		45,715	[2]	32,332	[2]	137,081	[2]	119,809
Operating lease right-of-use asset impairment	[3]	233		0		1,043		1,414
Sublease Income		(1,003)		(979)		(2,973)		(2,959)
Operating lease cost		114,112		$ 94,530		328,461		302,436
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability						291,289		117,959
Cash paid for operating lease liabilities						206,413		$ 210,971
LesseeOperatingLeaseLeasesNotYetCommencedLiability		$ 66,500				$ 66,500
[1] (1) Includes amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities. Includes variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs. Refer to Note 8, “ ASSET IMPAIRMENT ,” for details related to operating lease right-of-use asset impairment charges.

Asset Impairment (Details)

Asset Impairment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023	Feb. 03, 2024
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Property and equipment asset impairment	$ 5,266	$ 0	$ 6,023	$ 3,022
Asset Impairment Charges	5,499	0	7,066	4,436
Operating Lease, Right-of-Use Asset	798,290		798,290		$ 678,256
Retail Site
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Operating Lease, Impairment Loss	233	$ 0	1,043	$ 1,414
Fair Value, Nonrecurring
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Store Assets, including property and equipment and operating lease right-of-use assets	6,400		6,400
Operating Lease, Right-of-Use Asset	$ 5,100		$ 5,100

Rabbi Trust Assets (Details)

Rabbi Trust Assets (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands		Nov. 02, 2024	Feb. 03, 2024
Defined Benefit Plan, Plan Assets, Category [Line Items]
Restricted Investments, Noncurrent	[1]	$ 54,717	$ 53,685
Level 2
Defined Benefit Plan, Plan Assets, Category [Line Items]
Restricted Investments, Noncurrent	[1]	53,553	52,521
Level 1
Defined Benefit Plan, Plan Assets, Category [Line Items]
Restricted Investments, Noncurrent	[1]	$ 1,164	$ 1,164
[1] Level 1 assets consisted of investments in money market funds. Level 2 assets consisted of trust-owned life insurance policies.

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023	Feb. 03, 2024
Valuation Allowance [Line Items]
Pre-Tax Losses Without Tax Benefits Recognized	$ 7,700,000	$ 20,000,000	$ 22,300,000	$ 63,000,000
Valuation Allowance, Deferred Tax Asset, Increase (Decrease) Amount	1,200,000	3,000,000	3,400,000	9,600,000
Deferred Tax Assets, Net	39,500,000		39,500,000
Pre-Tax Losses Without Tax Benefits Recognized	7,700,000	20,000,000	22,300,000	63,000,000
Income Tax Expense (Benefit)	54,151,000	$ 39,617,000	119,394,000	$ 82,349,000
CHINA
Valuation Allowance [Line Items]
Deferred Tax Assets, Other	10,000,000		10,000,000		$ 7,600,000
JAPAN
Valuation Allowance [Line Items]
Deferred Tax Assets, Other	6,100,000		6,100,000		7,500,000
UNITED KINGDOM
Valuation Allowance [Line Items]
Deferred Tax Assets, Other	$ 13,100,000		$ 13,100,000		$ 12,600,000

Borrowings (Details)

Borrowings (Details) $ in Thousands	3 Months Ended			6 Months Ended	9 Months Ended
	Nov. 02, 2024 USD ($)	Aug. 03, 2024 USD ($)	May 04, 2024 USD ($)	Aug. 03, 2024 USD ($)	Nov. 02, 2024 USD ($)	Oct. 28, 2023 USD ($)	Jul. 15, 2024 USD ($)	Feb. 03, 2024 USD ($)	Apr. 29, 2021 USD ($)
Long-Term Borrowings [Line Items]
Loss on extinguishment of debt					$ 1,114	$ 1,276
Line of Credit Facility, Remaining Borrowing Capacity	$ 499,600				499,600
Long-term Debt, Excluding Current Maturities	0				0			$ 222,119
Schedule of Future Payments of the Term Loan Facility
ABL Facility, covenant terms, minimum remaining borrowing capacity	449,600				449,600
Letters of Credit Outstanding, Amount	(400)				(400)
sub limit
Schedule of Future Payments of the Term Loan Facility
Line of Credit, Current	62,500		$ 50,000		62,500
swing line
Schedule of Future Payments of the Term Loan Facility
Line of Credit, Current	30,000		$ 50,000		30,000
Revolving Credit Facility
Schedule of Future Payments of the Term Loan Facility
Line of Credit, Current	150,000				150,000
Senior Notes [Member]
Long-Term Borrowings [Line Items]
Debt Instrument, Repurchased Face Amount		$ 9,300		$ 9,300			$ 214,000
Loss on extinguishment of debt		$ 900			1,100
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate							8.75%
Maturity date				Jul. 15, 2025
Long-Term Debt, Gross	0				0
ABL Facility
Long-Term Borrowings [Line Items]
Maximum borrowing capacity	$ 500,000				$ 500,000				$ 400,000
Maturity date	Aug. 02, 2029		Apr. 29, 2026
ABL Facility, unused capacity, commitment fee percentage	0.25%
Schedule of Future Payments of the Term Loan Facility
Line Of Credit Facility Interest Rate Spread At Period End When Greater Than 50% of Loan Cap	0.0150		0.0125		0.0150
Line Of Credit Facility Interest Rate Spread At Period End When Less Than 50% of Loan Cap	0.0175		0.0150		0.0175
Base Rate Minimum ABL Facility | ABL Facility
Long-Term Borrowings [Line Items]
ABL Facility, unused capacity, commitment fee percentage			0.25%
Base Rate Maximum ABL Facility | ABL Facility
Long-Term Borrowings [Line Items]
ABL Facility, unused capacity, commitment fee percentage			0.375%

Borrowings Schedule of Short-te

Borrowings Schedule of Short-term borrowings (Details) $ in Millions	Nov. 02, 2024 USD ($)
Short-term debt disclosure [Abstract]
Line of Credit Facility, Remaining Borrowing Capacity	$ 499.6

Share-Based Compensation (Detai

Share-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	$ (2,388)	$ (10,310)	$ (69,613)	$ (29,079)
Payment, Tax Withholding, Share-based Payment Arrangement	2,388	10,310	69,613	29,079
Share-based compensation expense	9,527	9,684	30,123	29,331
Tax benefit recognized related to share-based compensation expense	1,287	1,080	3,805	3,163
Share-based Payment Arrangement, Exercise of Option, Tax Benefit	581	861	17,913	2,303
Share-based Payment Arrangement, Cancellation of Option, Tax Charge	0	0	0	(101)
Share-based Payment Arrangement, Discrete Income Tax Benefit (Charge)	581	861	17,913	2,202
Stock Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total grant date fair value of awards vested			267	1,292
Service-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	41,966		$ 41,966
Unrecognized compensation cost, weighted-average period of recognition			1 year 1 month 6 days
Total grant date fair value of awards granted			$ 29,096	26,237
Total grant date fair value of awards vested			21,679	23,051
Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	16,647		$ 16,647
Unrecognized compensation cost, weighted-average period of recognition			1 year 1 month 6 days
Total grant date fair value of awards granted			$ 6,483	6,300
Total grant date fair value of awards vested			9,659	0
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	6,163		$ 6,163
Unrecognized compensation cost, weighted-average period of recognition			1 year 1 month 6 days
Total grant date fair value of awards granted			$ 4,860	4,576
Total grant date fair value of awards vested			7,574	16,040
Additional Paid-in Capital [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(1,180)	(6,567)	(35,092)	(32,071)
Share-based compensation expense	$ 9,527	$ 9,684	$ 30,123	$ 29,331

Share-Based Compensation (Restr

Share-Based Compensation (Restricted Stock Units Activity) (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
		Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Exercise of Option, Tax Benefit		$ 581	$ 861	$ 17,913	$ 2,303
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021				25,600
Number of Underlying Shares, Forfeited				0
Number of Underlying Shares, Ending Balance at July 31, 2021		0		0
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance				$ 29.29
Weighted-Average Grant Date Fair Value, Forfeited				0
Weighted-Average Grant Date Fair Value, Ending Balance		$ 0		$ 0
Service-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 41,966		$ 41,966
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021				1,886,085
Number of Underlying Shares, Granted				236,530
Number of Underlying Shares, Adjustments for performance achievement				0
Number of Underlying Shares, Vested				(866,119)
Number of Underlying Shares, Forfeited				(75,993)
Number of Underlying Shares, Ending Balance at July 31, 2021		1,180,503		1,180,503
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance				$ 27.12
Weighted-Average Grant Date Fair Value, Granted				123.01
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement				0
Weighted-Average Grant Date Fair Value, Vested				25.03
Weighted-Average Grant Date Fair Value, Forfeited				35.65
Weighted-Average Grant Date Fair Value, Ending Balance		$ 47.41		$ 47.41
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition				1 year 1 month 6 days
Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 16,647		$ 16,647
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021				521,212
Number of Underlying Shares, Granted				53,775
Number of Underlying Shares, Adjustments for performance achievement				150,446
Number of Underlying Shares, Vested				(300,892)
Number of Underlying Shares, Forfeited				0
Number of Underlying Shares, Ending Balance at July 31, 2021	[1]	424,541		424,541
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance				$ 30.03
Weighted-Average Grant Date Fair Value, Granted				120.56
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement				32.10
Weighted-Average Grant Date Fair Value, Vested				32.10
Weighted-Average Grant Date Fair Value, Forfeited				0
Weighted-Average Grant Date Fair Value, Ending Balance		$ 40.76		$ 40.76
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition				1 year 1 month 6 days
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 6,163		$ 6,163
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021				260,619
Number of Underlying Shares, Granted				26,895
Number of Underlying Shares, Adjustments for performance achievement				75,227
Number of Underlying Shares, Vested				(150,454)
Number of Underlying Shares, Forfeited				0
Number of Underlying Shares, Ending Balance at July 31, 2021	[1]	212,287		212,287
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance				$ 43.90
Weighted-Average Grant Date Fair Value, Granted				180.71	$ 41.20
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement				50.34
Weighted-Average Grant Date Fair Value, Vested				50.34
Weighted-Average Grant Date Fair Value, Forfeited				0
Weighted-Average Grant Date Fair Value, Ending Balance		$ 58.95		$ 58.95
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition				1 year 1 month 6 days
[1] Unvested shares related to restricted stock units with performance-based and market-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can be achieved from zero up to 200% of their target vesting amount.

Share-Based Compensation (Res_2

Share-Based Compensation (Restricted Stock Units Assumptions) (Details) - $ / shares	9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Document Period End Date	Nov. 02, 2024
City Area Code	(614)
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date market price (in dollars per share)	$ 120.56	$ 28.36
Fair value (in dollars per share)	$ 180.71	$ 41.20
Price volatility	59%	63%
Expected term (years)	2 years 10 months 24 days	2 years 10 months 24 days
Risk-free interest rate	4.30%	4.60%
Dividend yield	0%	0%
Average volatility of peer companies	51.80%	66%
Average correlation coefficient of peer companies	0.4866	0.5295

Share-Based Compensation (Stock

Share-Based Compensation (Stock Appreciation Rights Activity) (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023
Stock Appreciation Rights Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021	25,600
Number of Underlying Shares, Exercised	(25,600)
Number of Underlying Shares, Forfeited	0
Number of Underlying Shares, Ending Balance at July 31, 2021	0
Number of Underlying shares, Stock appreciation rights exercisable	0
Stock Appreciation Rights, Weighted-Average Exercise Price
Weighted-Average Grant Date Fair Value, Beginning Balance	$ 29.29
Weighted-Average Exercise Price, Exercised	29.29
Weighted-Average Exercise Price, Forfeited or expired	0
Weighted-Average Grant Date Fair Value, Ending Balance	0
Weighted-Average Exercise Price, Stock appreciation rights exercisable	$ 0
Aggregate Intrinsic Value, Outstanding	$ 0
Aggregate Intrinsic Value, Stock appreciation rights exercisable	$ 0
Weighted-Average Remaining Contractual Life, Outstanding	0 years
Weighted-Average Remaining Contractual Life, Stock appreciation rights exercisable	0 years
Stock Appreciation Rights
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	$ 267	$ 1,292

Derivative Instruments (Outstan

Derivative Instruments (Outstanding Foreign Exchange Forward Contracts) (Details) - Foreign currency exchange forward contracts - USD ($) $ in Thousands		Nov. 02, 2024	Feb. 03, 2024
Designated As Hedging Instrument
Derivative [Line Items]
Derivative Asset, Statement of Financial Position [Extensible Enumeration]		Other Assets, Current	Other Assets, Current
Not Designated as Hedging Instruments
Derivative [Line Items]
Derivative Asset, Statement of Financial Position [Extensible Enumeration]		Other Assets, Current	Other Assets, Current
Euro Member Countries, Euro | Designated As Hedging Instrument
Derivative [Line Items]
Notional Amount	[1]	$ 69,300
United Kingdom, Pounds | Designated As Hedging Instrument
Derivative [Line Items]
Notional Amount	[1]	84,134
Canada, Dollars | Designated As Hedging Instrument
Derivative [Line Items]
Notional Amount	[1]	$ 28,480
[1] (1) Amounts reported are the U.S. dollar notional amounts outstanding as of November 2, 2024.

Derivative Instruments (Derivat

Derivative Instruments (Derivative Fair Values on the Condensed Consolidated Balance Sheets) (Details) - Foreign currency exchange forward contracts - USD ($) $ in Thousands	Nov. 02, 2024	Feb. 03, 2024
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	$ 2,143	$ 1,092
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	419	539
Designated As Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	2,143	1,090
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	$ 419	$ 539
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets, Current	Other Assets, Current
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities, Current	Accrued Liabilities, Current
Not Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	$ 0	$ 2
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	$ 0	$ 0
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets, Current	Other Assets, Current
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities, Current	Accrued Liabilities, Current

Derivative Instruments (Deriv_2

Derivative Instruments (Derivative Gains (Losses) on the Condensed Consolidated Statement of Operations) (Details) - Foreign currency exchange forward contracts - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Designated As Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from AOCL into Earnings (Effective Portion)	[1]	$ (351)	$ (326)	$ 659	$ (2,940)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	[2]	1,162	7,151	1,604	7,202
Not Designated as Hedging Instruments
Derivative Instruments, Gain (Loss) [Line Items]
Gain/(Loss)		$ 11	$ 2,193	$ 454	$ (239)
[1] Amount represents (loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization. Amount represents the change in fair value of derivative instruments.

Derivative Instruments (Details

Derivative Instruments (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023	Feb. 03, 2024
Derivative Instruments, Gain (Loss) [Line Items]
Length of time inventory sales hedged (in months)				12 months
Foreign currency exchange forward contracts | Designated As Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated AOCL into Income, Effective Portion, Net	[1]	$ (351)	$ (326)	$ 659	$ (2,940)
Foreign currency exchange forward contracts | Euro Member Countries, Euro | Designated As Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount	[2]	69,300		69,300
Foreign currency exchange forward contracts | United Kingdom, Pounds | Designated As Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount	[2]	84,134		84,134
Foreign currency exchange forward contracts | Canada, Dollars | Designated As Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount	[2]	28,480		28,480
Fair Value, Recurring [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other current assets	[3]	2,143		2,143		$ 1,092
Accrued expenses	[3]	419		419		539
Level 2 | Fair Value, Recurring [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other current assets		2,143		2,143		1,092	[3]
Accrued expenses	[3]	$ 419		$ 419		$ 539
[1] Amount represents (loss) gain reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization. (1) Amounts reported are the U.S. dollar notional amounts outstanding as of November 2, 2024. (3) Level 2 assets and liabilities consisted primarily of foreign currency exchange forward contracts.

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Nov. 02, 2024		Oct. 28, 2023		Nov. 02, 2024		Oct. 28, 2023
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	$ (134,991)		$ (138,405)		$ (135,968)		$ (137,527)
Other comprehensive income before reclassifications	1,246		2,109		3,292		(1,365)
Reclassified gain (loss) from AOCL	351	[1]	326	[2]	(659)	[1]	2,940	[2]
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent	(52)		(218)		(111)		(236)
Other comprehensive income	1,545		2,217		2,522		1,339
Ending balance at November 2, 2024	(133,446)		(136,188)		(133,446)		(136,188)
Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(134,928)		(136,178)		(136,532)		(132,653)
Other comprehensive income before reclassifications	84		(5,042)		1,688		(8,567)
Reclassified gain (loss) from AOCL	0		0		0		0
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent	0		0		0		0
Other comprehensive income	84		(5,042)		1,688		(8,567)
Ending balance at November 2, 2024	(134,844)		(141,220)		(134,844)		(141,220)
Unrealized Gain (Loss) on Derivative Financial Instruments
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(63)		(2,227)		564		(4,874)
Other comprehensive income before reclassifications	1,162		7,151		1,604		7,202
Reclassified gain (loss) from AOCL	351	[1]	326	[2]	(659)	[1]	2,940	[2]
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent	(52)		(218)		(111)		(236)
Other comprehensive income	1,461		7,259		834		9,906
Ending balance at November 2, 2024	$ 1,398		$ 5,032		$ 1,398		$ 5,032
[1] Amount represents loss reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income.

Segment Reporting (Segment Repo

Segment Reporting (Segment Reporting Information, by Segment) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Segment Reporting, Disclosure of Other Information about Entity's Reportable Segments [Abstract]
Segment Reporting, Factors Used to Identify Entity's Reportable Segments			The Company manages its business on a geographic basis, consisting of three reportable segments: Americas; EMEA; and APAC. Corporate functions and other income and expenses are evaluated on a consolidated basis and are not allocated to the Company’s segments, and therefore are included as a reconciling item between segment and total operating income. The Americas reportable segment includes the results of operations in North America and South America. The EMEA reportable segment includes the results of operations in Europe, the Middle East and Africa. The APAC reportable segment includes the results of operations in the Asia-Pacific region, including Asia and Oceania. Intersegment sales and transfers are recorded at cost and are treated as a transfer of inventory. All intercompany revenues are eliminated in consolidation and are not reviewed when evaluating segment performance.
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Net sales	$ 1,208,966	$ 1,056,431	$ 3,363,670	$ 2,827,770
Segment Reporting Information, Operating Income (Loss) [Abstract]
Operating Income (Loss)	179,282	138,020	484,756	261,870
Operating Segments [Member]
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Net sales	1,208,966	1,056,431	3,363,670	2,827,770
Segment Reporting Information, Operating Income (Loss) [Abstract]
Operating Income (Loss)	322,069	274,974	908,510	633,846
Americas [Member] | Operating Segments [Member]
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Net sales	986,449	867,566	2,707,794	2,264,415
Segment Reporting Information, Operating Income (Loss) [Abstract]
Operating Income (Loss)	304,542	257,440	832,009	590,948
EMEA [Member] | Operating Segments [Member]
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Net sales	181,592	157,976	546,052	468,045
Segment Reporting Information, Operating Income (Loss) [Abstract]
Operating Income (Loss)	21,708	20,795	84,249	49,170
Asia Pacific [Member] | Operating Segments [Member]
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Net sales	40,925	30,889	109,824	95,310
Segment Reporting Information, Operating Income (Loss) [Abstract]
Operating Income (Loss)	$ (4,181)	$ (3,261)	$ (7,748)	$ (6,272)

Segment Reporting (Reconciliati

Segment Reporting (Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Stores And Distribution Expense	$ 419,235	$ 383,883	$ 1,181,154	$ 1,072,662
Marketing General And Administrative Expense	190,001	162,510	538,352	449,643
Other Operating Income (Expense), Net	1,586	(1,256)	3,611	4,332
Operating Income (Loss)	179,282	138,020	484,756	261,870
Operating Segments [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating Income (Loss)	322,069	274,974	908,510	633,846
Operating Segments [Member] | Americas [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating Income (Loss)	304,542	257,440	832,009	590,948
Operating Segments [Member] | EMEA [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating Income (Loss)	21,708	20,795	84,249	49,170
Operating Segments [Member] | Asia Pacific [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating Income (Loss)	(4,181)	(3,261)	(7,748)	(6,272)
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Stores And Distribution Expense	(4,671)	(3,202)	(13,044)	(8,205)
Marketing General And Administrative Expense	(139,691)	(132,496)	(414,310)	(368,099)
Other Operating Income (Expense), Net	$ 1,575	$ (1,256)	$ 3,600	$ 4,328

Segment Reporting (Reconcilia_2

Segment Reporting (Reconciliation of Assets from Segment to Consolidated (Details) - USD ($) $ in Thousands	Nov. 02, 2024	Feb. 03, 2024
Segment Reporting, Asset Reconciling Item [Line Items]
Inventories	$ 692,596	$ 469,466
Assets	3,269,872	2,974,233
Total assets less inventory	2,577,276	2,504,767
Operating Segments [Member] | Americas [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Inventories	569,713	372,371
Operating Segments [Member] | EMEA [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Inventories	98,842	77,125
Operating Segments [Member] | Asia Pacific [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Inventories	$ 24,041	$ 19,970

Segment Reporting (Net Sales by

Segment Reporting (Net Sales by Brand) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023	Nov. 02, 2024	Oct. 28, 2023
Schedule of Revenue by Brand [Line Items]
Net sales	$ 1,208,966	$ 1,056,431	$ 3,363,670	$ 2,827,770
Hollister [Member]
Schedule of Revenue by Brand [Line Items]
Net sales	579,131	508,703	1,579,906	1,381,287
Abercrombie [Member]
Schedule of Revenue by Brand [Line Items]
Net sales	$ 629,835	$ 547,728	$ 1,783,764	$ 1,446,483